VFA
TXMD icon

Virtus Fund Advisers’s TherapeuticsMD TXMD Stock Holding History

Virtus Fund Advisers’s Portfolio TXMD Stock Details TXMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-172
Closed -$38K – 1896
2014
Q2 		$38K Buy
+172
New +$38.3K ﹤0.01% 2048

Other funds holding TXMD

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Virtus Fund Advisers's TXMD Position: Q3 2014 in Review

Virtus Fund Advisers sold out of TherapeuticsMD (TXMD) in Q3 2014, closing a stake of 172 shares — an estimated $38K sold.

Virtus Fund Advisers first reported a position in TXMD in Q2 2014 and held it in 1 quarter. The position peaked at $38K in Q2 2014. 82 funds tracked by Wall St. Rank hold TXMD as of Q3 2014.

  • Virtus Fund Advisers reported no remaining TherapeuticsMD position as of Q3 2014 after selling out during the quarter.
  • Virtus Fund Advisers sold 172 TherapeuticsMD shares in Q3 2014, an estimated $38K.
  • Virtus Fund Advisers first reported a position in TherapeuticsMD in Q2 2014 and held it in 1 quarter.
  • Virtus Fund Advisers's TherapeuticsMD position peaked at $38K in Q2 2014.
  • 82 funds tracked by Wall St. Rank held TherapeuticsMD as of Q3 2014.

Based on Virtus Fund Advisers's 13F filing for Q3 2014, filed 31 Oct 2014.